Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common stock	Additional paidin capital	Accumulated other comprehensive income	Accumulated deficit	Total
Balance at Beginning of period at Dec. 31, 2023	$ 24	$ 339,655	$ 91	$ (320,889)	$ 18,881
Balance at Beginning of period (in shares) at Dec. 31, 2023	24,494,675
Shares withheld for employee taxes		(339)			(339)
Shares withheld for employee taxes (in shares)	(49,377)
Foreign currency translation adjustment			7		7
Stockbased compensation expense		2,192			2,192
Net loss				(18,261)	(18,261)
Issuance of common stock under the employee stock purchase plan		164			164
Issuance of common stock under the employee stock purchase plan (in shares)	27,969
Vesting of share-based awards and exercise of stock options	$ 1	225			226
Vesting of share-based awards and exercise of stock options (in shares)	202,565
Balance at Ending period at Jun. 30, 2024	$ 25	341,897	98	(339,150)	2,870
Balance at Ending period (in shares) at Jun. 30, 2024	24,675,832
Balance at Beginning of period at Mar. 31, 2024	$ 25	340,812	97	(326,550)	14,384
Balance at Beginning of period (in shares) at Mar. 31, 2024	24,653,939
Shares withheld for employee taxes		(11)			(11)
Shares withheld for employee taxes (in shares)	(2,439)
Foreign currency translation adjustment			1		1
Stockbased compensation expense		1,090			1,090
Net loss				(12,600)	(12,600)
Vesting of share-based awards and exercise of stock options		6			6
Vesting of share-based awards and exercise of stock options (in shares)	24,332
Balance at Ending period at Jun. 30, 2024	$ 25	341,897	98	(339,150)	2,870
Balance at Ending period (in shares) at Jun. 30, 2024	24,675,832
Balance at Beginning of period at Dec. 31, 2024	$ 39	387,059	90	(358,730)	28,458
Balance at Beginning of period (in shares) at Dec. 31, 2024	39,395,712
Vesting of restricted stock units	$ 1				1
Vesting of restricted stock units (in shares)	231,011
Shares withheld for employee taxes		(180)			(180)
Shares withheld for employee taxes (in shares)	(69,863)
Foreign currency translation adjustment			3		3
Stockbased compensation expense		2,029			2,029
Net loss				(21,187)	(21,187)
Issuance of common stock under the employee stock purchase plan		60			60
Issuance of common stock under the employee stock purchase plan (in shares)	27,318
Balance at Ending period at Jun. 30, 2025	$ 40	388,968	93	(379,917)	9,184
Balance at Ending period (in shares) at Jun. 30, 2025	39,584,178
Balance at Beginning of period at Mar. 31, 2025	$ 40	387,986	91	(369,994)	18,123
Balance at Beginning of period (in shares) at Mar. 31, 2025	39,554,771
Vesting of restricted stock units (in shares)	32,731
Shares withheld for employee taxes		(3)			(3)
Shares withheld for employee taxes (in shares)	(3,324)
Foreign currency translation adjustment			2		2
Stockbased compensation expense		985			985
Net loss				(9,923)	(9,923)
Balance at Ending period at Jun. 30, 2025	$ 40	$ 388,968	$ 93	$ (379,917)	$ 9,184
Balance at Ending period (in shares) at Jun. 30, 2025	39,584,178